Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2014; 20(5): 1289-1297
Published online Feb 7, 2014. doi: 10.3748/wjg.v20.i5.1289
Published online Feb 7, 2014. doi: 10.3748/wjg.v20.i5.1289
All patients (n = 108) | F0 (n = 14) | P values of Mann-Whitney U test between F0 and F1 | F1 (n = 17) | P values of Mann-Whitney U test between F0-1 and F2 | F2 (n = 32) | P values of Mann-Whitney U test between F2 and F3 | F3 (n = 31) | P values of Mann-Whitney U test between F3 and F4 | F4 (n = 14) | |
Age (yr)1 | 59.5 (49.0-66.0) | 48.0 (41.0-60.0) | NS | 51.0 (41.8-65.5) | NS | 61.5 (51.5-66.5) | NS | 61.0 (52.0-67.0) | NS | 60.5 (54.0-66.0) |
Gender (female/male)2 | 52/56 | 8/6 | NS | 8/9 | NS | 15/17 | NS | 13/18 | NS | 8/6 |
BMI | 22.5 (20.5-24.6) | 22.0 (20.0-23.2) | NS | 23.5 (19.8-25.4) | NS | 23.0 (20.7-24.4) | NS | 23.2 (21.1-26.1) | NS | 21.9 (19.0-23.4) |
Fibrosis stage (F0/F1/F2/F3/F4) | 14/17/32/31/14 | - | - | - | - | - | ||||
Inflammatory grade (A0/A1/A2/A3) | 12/32/53/11 | 9/5/0/0 | 0.0261 | 2/15/0/0 | 0.0001 | 1/9/22/0 | 0.0060 | 0/2/22/7 | NS | 0/1/9/4 |
Steatosis grade (S0/S1/S/2/S3) | 42/42/14/10 | 8/5/0/1 | NS | 7/9/0/1 | NS | 10/11/6/5 | NS | 9/14/5/3 | NS | 8/3/3/0 |
AST (IU/L)1 | 44.0 (31.5-82.0) | 28.5 (24.0-38.0) | NS | 36.0 (23.0-41.3) | 0.0033 | 48.5 (36.5-101.5) | NS | 48.0 (42.5-85.3) | NS | 65.5 (37.0-88.0) |
ALT (IU/L)1 | 55.0 (35.0-91.5) | 37.5 (22.0-59.0) | NS | 39.0 (24.8-52.0) | 0.0095 | 65.0 (41.0-153.0) | NS | 70.0 (41.3-109.0) | NS | 64.0 (36.0-91.0) |
γ-GTP (IU/L)1 | 33.0 (23.5-75.0) | 23.0 (14.0-27.0) | 0.0802 | 28.0 (19.5-71.3) | NS | 39.5 (24.5-89.5) | NS | 41.0 (28.0-96.8) | 0.0329 | 30.5 (27.0-38.0) |
Platelet count (× 104/μL)1 | 14.3 (11.3-17.6) | 14.6 (11.7-20.2) | NS | 18.2 (16.6-21.2) | 0.0107 | 16.1 (14.0-17.4) | 0.0080 | 12.2 (11.3-14.3) | 0.0078 | 10.1 (7.1-11.6) |
Prothrombin time (INR)1 | 1.00 (0.96-1.06) | 0.95 (0.90-0.99) | NS | 0.96 (0.93-1.02) | NS | 1.00 (0.95-1.03) | 0.0144 | 1.03 (1.00-1.08) | 0.0229 | 1.10 (1.03-1.12) |
Albumin (g/dL)1 | 4.2 (4.0-4.5) | 4.4 (4.1-4.6) | NS | 4.4 (4.2-4.5) | NS | 4.3 (4.0-4.5) | 0.0524 | 4.1 (3.8-4.3) | NS | 4.0 (3.8-4.2) |
Total cholesterol (mg/dL)1 | 170 (150-188) | 193 (177-207) | 0.0619 | 169 (155-193) | NS | 172 (156-189) | 0.0615 | 159 (141-177) | NS | 160 (144-183) |
γ-globulin (g/dL)1 | 1.51 (1.33-1.79) | 1.28 (1.14-1.40) | 0.0262 | 1.40 (1.28-1.70) | NS | 1.44 (1.34-1.64) | 0.0067 | 1.63 (1.51-2.11) | NS | 1.66 (1.43-1.97) |
Hyaluronic acid (ng/mL)1 | 89 (49-206) | 39 (30-64) | NS | 49 (26-77) | 0.0041 | 89 (66-185) | 0.0601 | 184 (82-245) | 0.0291 | 232 (191-338) |
HCV genotype (1/2) | 81/26 | 10/4 | NS | 12/5 | NS | 22/9 | NS | 5/26 | NS | 11/3 |
HCV RNA (logIU/mL)1 | 6.6 (5.8-7.0) | 6.5 (6.0-6.9) | NS | 6.6 (5.4-7.0) | NS | 6.6 (5.8-7.1) | NS | 6.7 (5.9-7.1) | NS | 6.6 (6.3-6.8) |
Fibrosis area (%)1 | 2.63% (1.35-4.95) | 0.85% (0.41-1.04) | 0.0111 | 1.37% (0.73-1.85) | 0.0022 | 2.20% (1.62-2.74) | < 0.0001 | 4.83% (4.03-6.24) | < 0.0001 | 8.87% (8.04-10.52) |
Velocity of shear wave (m/s)1 | 1.38 (1.19-1.71) | 1.2 (1.0-1.3) | NS | 1.1 (1.0 -1.2) | 0.0010 | 1.3 (1.2-1.6) | 0.0014 | 1.6 (1.5-1.8) | 0.0008 | 2.1 (1.9-2.2) |
- Citation: Nishikawa T, Hashimoto S, Kawabe N, Harata M, Nitta Y, Murao M, Nakano T, Mizuno Y, Shimazaki H, Kan T, Nakaoka K, Takagawa Y, Ohki M, Ichino N, Osakabe K, Yoshioka K. Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis C. World J Gastroenterol 2014; 20(5): 1289-1297
- URL: https://www.wjgnet.com/1007-9327/full/v20/i5/1289.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i5.1289